Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;27:1273-1276

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dimsdale, J. E.
Right arrow Articles by Nelesen, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dimsdale, J. E.
Right arrow Articles by Nelesen, R.

(Hypertension. 1996;27:1273-1276.)
© 1996 American Heart Association, Inc.


Articles

Effect of Race and Hypertension on Plasma Amylin Concentrations

Joel E. Dimsdale; Orville Kolterman; Joy Koda; Richard Nelesen

From the Department of Psychiatry, University of California, San Diego (J.E.D., R.N.), and Amylin Pharmaceuticals, La Jolla, Calif (O.K., J.K.).

Correspondence to Dr Joel E. Dimsdale, UCSD, La Jolla, CA 92093-0804.

Abstract Amylin is a recently discovered peptide hormone composed of 37 amino acids that is cosecreted with insulin by pancreatic ß cells. Amylin has been reported to be present in increased amounts in insulin-resistant subjects who are hyperinsulinemic. Because blacks and whites differ in the prevalence of both hypertension and diabetes, we examined amylin levels in 77 individuals; 42 were black (11 hypertensive and 31 normotensive) and 35 were white (10 hypertensive and 25 normotensive) individuals who were either healthy control subjects or hypertensive subjects not receiving antihypertensive medication. Plasma amylin concentrations were measured in two separate monoclonal antibody–based immunofluorescent sandwich-type assays. The F002-2 capture antibody binds amylin plus at least two additional amylin-like peptides, and the F024-4 capture antibody detectably binds only the amylin peptide. There was a significant race-by-diagnosis interaction for levels of amylin immunoreactivity during a 2-hour glucose tolerance test (P<.005 for F002-2 antibody and P<.05 for F024-4 antibody). Highest levels were found in black hypertensive subjects. The results appear to fit with previously observed differences in metabolic status between blacks and whites and with the association between hypertension and alterations in metabolic status.


Key Words: amylin • insulin • glucose • race • peptides




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
K. Ku, K. Nakayama, Y. Saitoh, S. Nosaka, T. Kitano, T. Hanada, H. Nagami, K. Yamada, and K. Minami
Long-Term Follow-up (8 to 17 Years) After Thromboexclusion Operation for Thoracic Aortic Aneurysms
Ann. Thorac. Surg., August 1, 1997; 64(2): 399 - 403.
[Abstract] [Full Text]